In 2023, the FDA required the manufacturers of Ozempic and Wegovy to update the drugs warning label to include the risk of bowel obstruction, a severe gastrointestinal side effect
Tama B et al
PlexusDx Precision Peptide Genetic Test examines key variants (GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, MC4R rs17782313) that may help provide context for your provider's medication selection
Lam CSP, Ramasundarahettige C, Branch KRH et al (2022) Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial
$250 / treatment Supports joints and soft tissue healing, reduces inflammation, and promotes gut health
If you suspect degradation, discard it